Pharma & Healthcare

Global Biologic Medical Product Market Research Report 2025

The global market for Biologic Medical Product was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Biological products include a wide range of products such as vaccines, blood and blood components, allergenics, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living entities such as cells and tissues. Biologics are isolated from a variety of natural sources - human, animal, or microorganism - and may be produced by biotechnology methods and other cutting-edge technologies. Gene-based and cellular biologics, for example, often are at the forefront of biomedical research, and may be used to treat a variety of medical conditions for which no other treatments are available.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biologic Medical Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologic Medical Product.
The Biologic Medical Product market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biologic Medical Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologic Medical Product companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Amgen
AbbVie
Pfizer
Sanofi-Aventis
Johnson & Johnson
Novo Nordisk
Eli Lilly
Novartis
Merck
Sun
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Ganlee
United Laboratories
Teva Pharmaceutical
MYLAN
Sun Pharma
Segment by Type
Monoclonal Antibodies
Colony-Stimulating Factor
Interferon
Erythropoietin
Insulin
Vaccines
Growth Hormones
Others
Segment by Application
Tumor
Diabetes
Cardiovascular
Hemophilia
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologic Medical Product company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologic Medical Product Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibodies
1.2.3 Colony-Stimulating Factor
1.2.4 Interferon
1.2.5 Erythropoietin
1.2.6 Insulin
1.2.7 Vaccines
1.2.8 Growth Hormones
1.2.9 Others
1.3 Market by Application
1.3.1 Global Biologic Medical Product Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologic Medical Product Market Perspective (2020-2031)
2.2 Global Biologic Medical Product Growth Trends by Region
2.2.1 Global Biologic Medical Product Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biologic Medical Product Historic Market Size by Region (2020-2025)
2.2.3 Biologic Medical Product Forecasted Market Size by Region (2026-2031)
2.3 Biologic Medical Product Market Dynamics
2.3.1 Biologic Medical Product Industry Trends
2.3.2 Biologic Medical Product Market Drivers
2.3.3 Biologic Medical Product Market Challenges
2.3.4 Biologic Medical Product Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologic Medical Product Players by Revenue
3.1.1 Global Top Biologic Medical Product Players by Revenue (2020-2025)
3.1.2 Global Biologic Medical Product Revenue Market Share by Players (2020-2025)
3.2 Global Biologic Medical Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biologic Medical Product Revenue
3.4 Global Biologic Medical Product Market Concentration Ratio
3.4.1 Global Biologic Medical Product Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologic Medical Product Revenue in 2024
3.5 Global Key Players of Biologic Medical Product Head office and Area Served
3.6 Global Key Players of Biologic Medical Product, Product and Application
3.7 Global Key Players of Biologic Medical Product, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologic Medical Product Breakdown Data by Type
4.1 Global Biologic Medical Product Historic Market Size by Type (2020-2025)
4.2 Global Biologic Medical Product Forecasted Market Size by Type (2026-2031)
5 Biologic Medical Product Breakdown Data by Application
5.1 Global Biologic Medical Product Historic Market Size by Application (2020-2025)
5.2 Global Biologic Medical Product Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biologic Medical Product Market Size (2020-2031)
6.2 North America Biologic Medical Product Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biologic Medical Product Market Size by Country (2020-2025)
6.4 North America Biologic Medical Product Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biologic Medical Product Market Size (2020-2031)
7.2 Europe Biologic Medical Product Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biologic Medical Product Market Size by Country (2020-2025)
7.4 Europe Biologic Medical Product Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biologic Medical Product Market Size (2020-2031)
8.2 Asia-Pacific Biologic Medical Product Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biologic Medical Product Market Size by Region (2020-2025)
8.4 Asia-Pacific Biologic Medical Product Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biologic Medical Product Market Size (2020-2031)
9.2 Latin America Biologic Medical Product Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biologic Medical Product Market Size by Country (2020-2025)
9.4 Latin America Biologic Medical Product Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologic Medical Product Market Size (2020-2031)
10.2 Middle East & Africa Biologic Medical Product Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biologic Medical Product Market Size by Country (2020-2025)
10.4 Middle East & Africa Biologic Medical Product Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Biologic Medical Product Introduction
11.1.4 Roche Revenue in Biologic Medical Product Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Biologic Medical Product Introduction
11.2.4 Amgen Revenue in Biologic Medical Product Business (2020-2025)
11.2.5 Amgen Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Biologic Medical Product Introduction
11.3.4 AbbVie Revenue in Biologic Medical Product Business (2020-2025)
11.3.5 AbbVie Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Biologic Medical Product Introduction
11.4.4 Pfizer Revenue in Biologic Medical Product Business (2020-2025)
11.4.5 Pfizer Recent Development
11.5 Sanofi-Aventis
11.5.1 Sanofi-Aventis Company Details
11.5.2 Sanofi-Aventis Business Overview
11.5.3 Sanofi-Aventis Biologic Medical Product Introduction
11.5.4 Sanofi-Aventis Revenue in Biologic Medical Product Business (2020-2025)
11.5.5 Sanofi-Aventis Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Biologic Medical Product Introduction
11.6.4 Johnson & Johnson Revenue in Biologic Medical Product Business (2020-2025)
11.6.5 Johnson & Johnson Recent Development
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Details
11.7.2 Novo Nordisk Business Overview
11.7.3 Novo Nordisk Biologic Medical Product Introduction
11.7.4 Novo Nordisk Revenue in Biologic Medical Product Business (2020-2025)
11.7.5 Novo Nordisk Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Biologic Medical Product Introduction
11.8.4 Eli Lilly Revenue in Biologic Medical Product Business (2020-2025)
11.8.5 Eli Lilly Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Biologic Medical Product Introduction
11.9.4 Novartis Revenue in Biologic Medical Product Business (2020-2025)
11.9.5 Novartis Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Biologic Medical Product Introduction
11.10.4 Merck Revenue in Biologic Medical Product Business (2020-2025)
11.10.5 Merck Recent Development
11.11 Sun
11.11.1 Sun Company Details
11.11.2 Sun Business Overview
11.11.3 Sun Biologic Medical Product Introduction
11.11.4 Sun Revenue in Biologic Medical Product Business (2020-2025)
11.11.5 Sun Recent Development
11.12 3sbio
11.12.1 3sbio Company Details
11.12.2 3sbio Business Overview
11.12.3 3sbio Biologic Medical Product Introduction
11.12.4 3sbio Revenue in Biologic Medical Product Business (2020-2025)
11.12.5 3sbio Recent Development
11.13 Changchun High Tech
11.13.1 Changchun High Tech Company Details
11.13.2 Changchun High Tech Business Overview
11.13.3 Changchun High Tech Biologic Medical Product Introduction
11.13.4 Changchun High Tech Revenue in Biologic Medical Product Business (2020-2025)
11.13.5 Changchun High Tech Recent Development
11.14 CP Guojian
11.14.1 CP Guojian Company Details
11.14.2 CP Guojian Business Overview
11.14.3 CP Guojian Biologic Medical Product Introduction
11.14.4 CP Guojian Revenue in Biologic Medical Product Business (2020-2025)
11.14.5 CP Guojian Recent Development
11.15 Biotech
11.15.1 Biotech Company Details
11.15.2 Biotech Business Overview
11.15.3 Biotech Biologic Medical Product Introduction
11.15.4 Biotech Revenue in Biologic Medical Product Business (2020-2025)
11.15.5 Biotech Recent Development
11.16 Gelgen
11.16.1 Gelgen Company Details
11.16.2 Gelgen Business Overview
11.16.3 Gelgen Biologic Medical Product Introduction
11.16.4 Gelgen Revenue in Biologic Medical Product Business (2020-2025)
11.16.5 Gelgen Recent Development
11.17 Innovent
11.17.1 Innovent Company Details
11.17.2 Innovent Business Overview
11.17.3 Innovent Biologic Medical Product Introduction
11.17.4 Innovent Revenue in Biologic Medical Product Business (2020-2025)
11.17.5 Innovent Recent Development
11.18 Ganlee
11.18.1 Ganlee Company Details
11.18.2 Ganlee Business Overview
11.18.3 Ganlee Biologic Medical Product Introduction
11.18.4 Ganlee Revenue in Biologic Medical Product Business (2020-2025)
11.18.5 Ganlee Recent Development
11.19 United Laboratories
11.19.1 United Laboratories Company Details
11.19.2 United Laboratories Business Overview
11.19.3 United Laboratories Biologic Medical Product Introduction
11.19.4 United Laboratories Revenue in Biologic Medical Product Business (2020-2025)
11.19.5 United Laboratories Recent Development
11.20 Teva Pharmaceutical
11.20.1 Teva Pharmaceutical Company Details
11.20.2 Teva Pharmaceutical Business Overview
11.20.3 Teva Pharmaceutical Biologic Medical Product Introduction
11.20.4 Teva Pharmaceutical Revenue in Biologic Medical Product Business (2020-2025)
11.20.5 Teva Pharmaceutical Recent Development
11.21 MYLAN
11.21.1 MYLAN Company Details
11.21.2 MYLAN Business Overview
11.21.3 MYLAN Biologic Medical Product Introduction
11.21.4 MYLAN Revenue in Biologic Medical Product Business (2020-2025)
11.21.5 MYLAN Recent Development
11.22 Sun Pharma
11.22.1 Sun Pharma Company Details
11.22.2 Sun Pharma Business Overview
11.22.3 Sun Pharma Biologic Medical Product Introduction
11.22.4 Sun Pharma Revenue in Biologic Medical Product Business (2020-2025)
11.22.5 Sun Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Biologic Medical Product Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Colony-Stimulating Factor
Table 4. Key Players of Interferon
Table 5. Key Players of Erythropoietin
Table 6. Key Players of Insulin
Table 7. Key Players of Vaccines
Table 8. Key Players of Growth Hormones
Table 9. Global Biologic Medical Product Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Biologic Medical Product Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Biologic Medical Product Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Biologic Medical Product Market Share by Region (2020-2025)
Table 13. Global Biologic Medical Product Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Biologic Medical Product Market Share by Region (2026-2031)
Table 15. Biologic Medical Product Market Trends
Table 16. Biologic Medical Product Market Drivers
Table 17. Biologic Medical Product Market Challenges
Table 18. Biologic Medical Product Market Restraints
Table 19. Global Biologic Medical Product Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Biologic Medical Product Market Share by Players (2020-2025)
Table 21. Global Top Biologic Medical Product Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic Medical Product as of 2024)
Table 22. Ranking of Global Top Biologic Medical Product Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Biologic Medical Product Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Biologic Medical Product, Headquarters and Area Served
Table 25. Global Key Players of Biologic Medical Product, Product and Application
Table 26. Global Key Players of Biologic Medical Product, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Biologic Medical Product Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Biologic Medical Product Revenue Market Share by Type (2020-2025)
Table 30. Global Biologic Medical Product Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Biologic Medical Product Revenue Market Share by Type (2026-2031)
Table 32. Global Biologic Medical Product Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Biologic Medical Product Revenue Market Share by Application (2020-2025)
Table 34. Global Biologic Medical Product Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Biologic Medical Product Revenue Market Share by Application (2026-2031)
Table 36. North America Biologic Medical Product Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Biologic Medical Product Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Biologic Medical Product Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Biologic Medical Product Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Biologic Medical Product Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Biologic Medical Product Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Biologic Medical Product Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Biologic Medical Product Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Biologic Medical Product Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Biologic Medical Product Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Biologic Medical Product Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Biologic Medical Product Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Biologic Medical Product Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Biologic Medical Product Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Biologic Medical Product Market Size by Country (2026-2031) & (US$ Million)
Table 51. Roche Company Details
Table 52. Roche Business Overview
Table 53. Roche Biologic Medical Product Product
Table 54. Roche Revenue in Biologic Medical Product Business (2020-2025) & (US$ Million)
Table 55. Roche Recent Development
Table 56. Amgen Company Details
Table 57. Amgen Business Overview
Table 58. Amgen Biologic Medical Product Product
Table 59. Amgen Revenue in Biologic Medical Product Business (2020-2025) & (US$ Million)
Table 60. Amgen Recent Development
Table 61. AbbVie Company Details
Table 62. AbbVie Business Overview
Table 63. AbbVie Biologic Medical Product Product
Table 64. AbbVie Revenue in Biologic Medical Product Business (2020-2025) & (US$ Million)
Table 65. AbbVie Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Biologic Medical Product Product
Table 69. Pfizer Revenue in Biologic Medical Product Business (2020-2025) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Sanofi-Aventis Company Details
Table 72. Sanofi-Aventis Business Overview
Table 73. Sanofi-Aventis Biologic Medical Product Product
Table 74. Sanofi-Aventis Revenue in Biologic Medical Product Business (2020-2025) & (US$ Million)
Table 75. Sanofi-Aventis Recent Development
Table 76. Johnson & Johnson Company Details
Table 77. Johnson & Johnson Business Overview
Table 78. Johnson & Johnson Biologic Medical Product Product
Table 79. Johnson & Johnson Revenue in Biologic Medical Product Business (2020-2025) & (US$ Million)
Table 80. Johnson & Johnson Recent Development
Table 81. Novo Nordisk Company Details
Table 82. Novo Nordisk Business Overview
Table 83. Novo Nordisk Biologic Medical Product Product
Table 84. Novo Nordisk Revenue in Biologic Medical Product Business (2020-2025) & (US$ Million)
Table 85. Novo Nordisk Recent Development
Table 86. Eli Lilly Company Details
Table 87. Eli Lilly Business Overview
Table 88. Eli Lilly Biologic Medical Product Product
Table 89. Eli Lilly Revenue in Biologic Medical Product Business (2020-2025) & (US$ Million)
Table 90. Eli Lilly Recent Development
Table 91. Novartis Company Details
Table 92. Novartis Business Overview
Table 93. Novartis Biologic Medical Product Product
Table 94. Novartis Revenue in Biologic Medical Product Business (2020-2025) & (US$ Million)
Table 95. Novartis Recent Development
Table 96. Merck Company Details
Table 97. Merck Business Overview
Table 98. Merck Biologic Medical Product Product
Table 99. Merck Revenue in Biologic Medical Product Business (2020-2025) & (US$ Million)
Table 100. Merck Recent Development
Table 101. Sun Company Details
Table 102. Sun Business Overview
Table 103. Sun Biologic Medical Product Product
Table 104. Sun Revenue in Biologic Medical Product Business (2020-2025) & (US$ Million)
Table 105. Sun Recent Development
Table 106. 3sbio Company Details
Table 107. 3sbio Business Overview
Table 108. 3sbio Biologic Medical Product Product
Table 109. 3sbio Revenue in Biologic Medical Product Business (2020-2025) & (US$ Million)
Table 110. 3sbio Recent Development
Table 111. Changchun High Tech Company Details
Table 112. Changchun High Tech Business Overview
Table 113. Changchun High Tech Biologic Medical Product Product
Table 114. Changchun High Tech Revenue in Biologic Medical Product Business (2020-2025) & (US$ Million)
Table 115. Changchun High Tech Recent Development
Table 116. CP Guojian Company Details
Table 117. CP Guojian Business Overview
Table 118. CP Guojian Biologic Medical Product Product
Table 119. CP Guojian Revenue in Biologic Medical Product Business (2020-2025) & (US$ Million)
Table 120. CP Guojian Recent Development
Table 121. Biotech Company Details
Table 122. Biotech Business Overview
Table 123. Biotech Biologic Medical Product Product
Table 124. Biotech Revenue in Biologic Medical Product Business (2020-2025) & (US$ Million)
Table 125. Biotech Recent Development
Table 126. Gelgen Company Details
Table 127. Gelgen Business Overview
Table 128. Gelgen Biologic Medical Product Product
Table 129. Gelgen Revenue in Biologic Medical Product Business (2020-2025) & (US$ Million)
Table 130. Gelgen Recent Development
Table 131. Innovent Company Details
Table 132. Innovent Business Overview
Table 133. Innovent Biologic Medical Product Product
Table 134. Innovent Revenue in Biologic Medical Product Business (2020-2025) & (US$ Million)
Table 135. Innovent Recent Development
Table 136. Ganlee Company Details
Table 137. Ganlee Business Overview
Table 138. Ganlee Biologic Medical Product Product
Table 139. Ganlee Revenue in Biologic Medical Product Business (2020-2025) & (US$ Million)
Table 140. Ganlee Recent Development
Table 141. United Laboratories Company Details
Table 142. United Laboratories Business Overview
Table 143. United Laboratories Biologic Medical Product Product
Table 144. United Laboratories Revenue in Biologic Medical Product Business (2020-2025) & (US$ Million)
Table 145. United Laboratories Recent Development
Table 146. Teva Pharmaceutical Company Details
Table 147. Teva Pharmaceutical Business Overview
Table 148. Teva Pharmaceutical Biologic Medical Product Product
Table 149. Teva Pharmaceutical Revenue in Biologic Medical Product Business (2020-2025) & (US$ Million)
Table 150. Teva Pharmaceutical Recent Development
Table 151. MYLAN Company Details
Table 152. MYLAN Business Overview
Table 153. MYLAN Biologic Medical Product Product
Table 154. MYLAN Revenue in Biologic Medical Product Business (2020-2025) & (US$ Million)
Table 155. MYLAN Recent Development
Table 156. Sun Pharma Company Details
Table 157. Sun Pharma Business Overview
Table 158. Sun Pharma Biologic Medical Product Product
Table 159. Sun Pharma Revenue in Biologic Medical Product Business (2020-2025) & (US$ Million)
Table 160. Sun Pharma Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
Table 164. Authors List of This Report


List of Figures
Figure 1. Biologic Medical Product Picture
Figure 2. Global Biologic Medical Product Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Biologic Medical Product Market Share by Type: 2024 VS 2031
Figure 4. Monoclonal Antibodies Features
Figure 5. Colony-Stimulating Factor Features
Figure 6. Interferon Features
Figure 7. Erythropoietin Features
Figure 8. Insulin Features
Figure 9. Vaccines Features
Figure 10. Growth Hormones Features
Figure 11. Others Features
Figure 12. Global Biologic Medical Product Market Size by Application (2020-2031) & (US$ Million)
Figure 13. Global Biologic Medical Product Market Share by Application: 2024 VS 2031
Figure 14. Tumor Case Studies
Figure 15. Diabetes Case Studies
Figure 16. Cardiovascular Case Studies
Figure 17. Hemophilia Case Studies
Figure 18. Others Case Studies
Figure 19. Biologic Medical Product Report Years Considered
Figure 20. Global Biologic Medical Product Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 21. Global Biologic Medical Product Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 22. Global Biologic Medical Product Market Share by Region: 2024 VS 2031
Figure 23. Global Biologic Medical Product Market Share by Players in 2024
Figure 24. Global Top Biologic Medical Product Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic Medical Product as of 2024)
Figure 25. The Top 10 and 5 Players Market Share by Biologic Medical Product Revenue in 2024
Figure 26. North America Biologic Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. North America Biologic Medical Product Market Share by Country (2020-2031)
Figure 28. United States Biologic Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Canada Biologic Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Europe Biologic Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Europe Biologic Medical Product Market Share by Country (2020-2031)
Figure 32. Germany Biologic Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. France Biologic Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. U.K. Biologic Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Italy Biologic Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Russia Biologic Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Nordic Countries Biologic Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Biologic Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Biologic Medical Product Market Share by Region (2020-2031)
Figure 40. China Biologic Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Japan Biologic Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. South Korea Biologic Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Biologic Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. India Biologic Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Australia Biologic Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Latin America Biologic Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Latin America Biologic Medical Product Market Share by Country (2020-2031)
Figure 48. Mexico Biologic Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Brazil Biologic Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Middle East & Africa Biologic Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Middle East & Africa Biologic Medical Product Market Share by Country (2020-2031)
Figure 52. Turkey Biologic Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Biologic Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. UAE Biologic Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. Roche Revenue Growth Rate in Biologic Medical Product Business (2020-2025)
Figure 56. Amgen Revenue Growth Rate in Biologic Medical Product Business (2020-2025)
Figure 57. AbbVie Revenue Growth Rate in Biologic Medical Product Business (2020-2025)
Figure 58. Pfizer Revenue Growth Rate in Biologic Medical Product Business (2020-2025)
Figure 59. Sanofi-Aventis Revenue Growth Rate in Biologic Medical Product Business (2020-2025)
Figure 60. Johnson & Johnson Revenue Growth Rate in Biologic Medical Product Business (2020-2025)
Figure 61. Novo Nordisk Revenue Growth Rate in Biologic Medical Product Business (2020-2025)
Figure 62. Eli Lilly Revenue Growth Rate in Biologic Medical Product Business (2020-2025)
Figure 63. Novartis Revenue Growth Rate in Biologic Medical Product Business (2020-2025)
Figure 64. Merck Revenue Growth Rate in Biologic Medical Product Business (2020-2025)
Figure 65. Sun Revenue Growth Rate in Biologic Medical Product Business (2020-2025)
Figure 66. 3sbio Revenue Growth Rate in Biologic Medical Product Business (2020-2025)
Figure 67. Changchun High Tech Revenue Growth Rate in Biologic Medical Product Business (2020-2025)
Figure 68. CP Guojian Revenue Growth Rate in Biologic Medical Product Business (2020-2025)
Figure 69. Biotech Revenue Growth Rate in Biologic Medical Product Business (2020-2025)
Figure 70. Gelgen Revenue Growth Rate in Biologic Medical Product Business (2020-2025)
Figure 71. Innovent Revenue Growth Rate in Biologic Medical Product Business (2020-2025)
Figure 72. Ganlee Revenue Growth Rate in Biologic Medical Product Business (2020-2025)
Figure 73. United Laboratories Revenue Growth Rate in Biologic Medical Product Business (2020-2025)
Figure 74. Teva Pharmaceutical Revenue Growth Rate in Biologic Medical Product Business (2020-2025)
Figure 75. MYLAN Revenue Growth Rate in Biologic Medical Product Business (2020-2025)
Figure 76. Sun Pharma Revenue Growth Rate in Biologic Medical Product Business (2020-2025)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies